🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The investigators hypothesize that patients with mCRC RAS-mutant eligible f...
Status
Recruiting
Location
Istituto Nazionale Tumori | "Fondazione Pascale"
Start Date
2025-10-16
Trial ID
NCT07213570
Treatments Being Tested
Brief Summary The goal of this single-arm Phase II clinical trial is to le...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-09
Trial ID
NCT07164690
Treatments Being Tested
The goal of this clinical trial is to evaluate the efficacy and safety of c...
Status
Not Yet Recruiting
Location
Zhongda Hospital Affiliated to Southeast University, Department of Interventional and Vascular Surgery
Start Date
2025-09-30
Trial ID
NCT07187284
This multicenter, double-blind, placebo-controlled, randomized study will e...
Status
Completed
Location
Medizinische Universität Graz; Universitätsklinik für Neurologie
Start Date
2013-08-19
Trial ID
NCT01860638
Treatments Being Tested
The primary purpose of this study is to describe the Psoriatic Arthritis (P...
Status
Completed
Location
Hôpital Edouard Herriot
Start Date
2017-04-25
Trial ID
NCT03336281
Treatments Being Tested
This is an open-label, non-randomized, multi-center study of lapatinib plus...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-04
Trial ID
NCT01138046
Treatments Being Tested
This is a Phase 1/2(b), sequential, dose escalation, open-label, randomized...
Status
Terminated
Location
Research Site
Start Date
2015-06
Trial ID
NCT02401542
This study will evaluate zoledronic acid's anti-cancer effects and Circulat...
Status
Completed
Location
Highlands Oncology Group
Start Date
2010-06
Trial ID
NCT01129336
Treatments Being Tested
This is a randomized phase II study designed to evaluate the effect of loca...
Status
Withdrawn
Location
Multiple Locations
Start Date
2020-11-04
Trial ID
NCT04485026
Treatments Being Tested
This study plans to initiate a prospective, randomized controlled trial to ...
Status
Recruiting
Location
Liaoning Cancer Hospital & Institute
Start Date
2025-07-01
Trial ID
NCT07657130
Treatments Being Tested